Product NDC: | 31722-551 |
Proprietary Name: | Levocetirizine Dihydrochloride |
Non Proprietary Name: | Levocetirizine Dihydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Levocetirizine Dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 31722-551 |
Labeler Name: | Camber Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091264 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120629 |
Package NDC: | 31722-551-30 |
Package Description: | 30 TABLET in 1 BOTTLE (31722-551-30) |
NDC Code | 31722-551-30 |
Proprietary Name | Levocetirizine Dihydrochloride |
Package Description | 30 TABLET in 1 BOTTLE (31722-551-30) |
Product NDC | 31722-551 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levocetirizine Dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120629 |
Marketing Category Name | ANDA |
Labeler Name | Camber Pharmaceuticals, Inc. |
Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |